Generics of AstraZeneca Plc's extended release Toprol XL make up about 90 percent of physicians' orders for the drug. The copycat drugs are made by Wockhardt Ltd. and Dr. Reddy's Laboratories Ltd., both of which are based in India, and Mylan Inc. and Actavis Plc in the U.S.
Complaints against the drug, known generically as metoprolol succinate, cite both a lack of effectiveness and troublesome side effects, according to a review of 3,425 adverse incident reports by Bloomberg News. While the reports generally don't identify manufacturers, the Food and Drug Administration tests will focus on whether the copies are chemically the same as the original, the funding request shows.
"The FDA will continue to monitor and review available safety and other information related to metoprolol succinate extended release products and take any further action as appropriate," said Sandy Walsh, a spokeswoman, in an e-mail.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
